Argus cuts Oracle stock price target on backlog concerns By Investing.com

Oracle reported fiscal Q3 revenue of $17.2B versus a $16.9B consensus, with Infrastructure-as-a-Service revenue up 84% YoY to $4.9B and Cloud Database growth accelerating 35% YoY. The stock has fallen ~45% over six months and trades at $159.16 (52-week high $345.72); Argus cut its price target to $225 from $384 and Stifel cut PT to $220 while Mizuho and others remain bullish (Mizuho PT $400). Management raised guidance, increased FY2026 capex and debt to expand cloud capacity to meet strong demand for generative AI, and 16 analysts have raised earnings estimates despite some valuation concerns.

Analysis

Oracle’s push to become the enterprise “steward” of data and its multicloud distribution deals create a two-tier capture: hyperscalers get model hosting economics while Oracle captures higher-margin management, support and data-control annuities. The obvious beneficiary chain is server/accelerator OEMs and memory vendors — incremental AI workloads translate into sustained hardware refresh cycles rather than one-off migrations, extending the monetization window beyond a single migration project.

The immediate execution risk is capacity and go-to-market cadence: elevated capex and incremental debt buy time but compress free cash flow for quarters, making the story binary over a 6–18 month window — either backlog converts as customers ramp AI workloads or enterprise buyers pause while hyperscalers bundle cheaper model access. Market catalysts to watch are explicit capacity utilization disclosures, large multi-year enterprise AI contracts (including revenue recognition timing), and any hyperscaler moves to bundle first-party AI models into infra credits.

Consensus is underweighting the stickiness of enterprise data governance and the resulting switching friction: customers with regulated or sensitive data are more likely to accept higher unit costs for demonstrable data control, which favors Oracle’s positioning and could support sustained ASPs for database plus AI stack. Conversely, the crowd is overlooking a credible downside path where hyperscalers win via model bundling and developer ecosystems — that would depress pricing and materially extend the conversion timeline.

If Oracle successfully converts a material tranche of the backlog into recurring AI workloads, expect a multi-quarter re-rating driven by margin expansion on software/managed services and higher gross leverage on capex; failure to do so would show up quickly in bookings-to-revenue conversion and push multiple compression. Timeframes: watch for 3–6 month signals in bookings cadence and 6–18 month signals in capacity utilization and free cash flow trends.

Key Decisions for Investors

• Buy a cautious asymmetric option position to express backlog conversion: ORCL 12-month calendar call spread—buy a +40% OTM 12-month call and sell a +80% OTM 12-month call (notional sized to risk 1–2% of portfolio). R/R: limited premium loss vs ~2x–3x upside if enterprise AI workloads accelerate and multiple re-rates over 12 months.
• Relative-value pair: go long ORCL / short MSFT (equal notional) for 6–12 months to play data-governance capture vs hyperscaler bundling. R/R: if Oracle wins sticky enterprise deals, expect 15–35% relative outperformance; tail risk is symmetrical if hyperscalers materially undercut pricing or win large model exclusives.
• Supply-chain lever: long SMCI (or long-dated SMCI calls) for 6–12 months to play accelerated server refresh and custom AI rack demand from enterprise/cloud projects. R/R: pay premium for optionality; hardware wins can deliver 30–70% upside if order flow remains strong, downside limited to option premium or equity drawdown.
• Credit/capital structure play: accumulate ORCL IG bonds or 3–5 year CDS protection sold if spread >120–150bps over comparable Treasuries (size to risk appetite). R/R: capture carry and potential spread tightening if backlog converts and leverage improves; risk is credit-rating pressure if revenue conversion stalls and FCF weakens.